Aqueous Humor Induces Transforming Growth Factor-β (TGF-β)-Producing Regulatory T-Cells

REFERENCES

• Medawar P. Immunity to homologous grafted skin: III. the fate of skin homografts transplanted to the brain to subcutaneous tissue, and to the anterior chamber of the eye. Brit. J. Exp. Path. 1948; 29: 58–69
   PubMed Web of Science ®Google Scholar
• Barker C F, Billingham R E. Immunologically privileged sites. Adv. Immunol 1977; 25: 1–54
   PubMed Web of Science ®Google Scholar
• Kaplan H J, Streilein J W. Immune response to immunization via the anterior chamber of the eye: I. F1 lymphocyte-induced-immune deviation. J. Immunol 1977; 118: 809–814
   PubMed Web of Science ®Google Scholar
• Streilein J W. Ocular immune privilege in the immunosuppressive intraocular microenvironment. Ocul. Immunol. Inflamm 1995; 3: 139–143
   PubMedGoogle Scholar
• Taylor A W. Immunoregulation of the ocular effector responses by soluble factors in aqueous humor. Reg. Immunol. 1994; 6: 52–57
   Google Scholar
• Kaiser C, Ksander B, Streilein J. Inhibition of lymphocyte proliferation by aqueous humor. Reg. Immunol. 1989; 2: 42–49
   PubMedGoogle Scholar
• Streilein J W, Wilbanks G A, Taylor A W, Cousins S. Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review. Curr. Eye Res. 1992; 11: 41–47, (Suppl.)
   PubMed Web of Science ®Google Scholar
• Cousins S W, McCabe M M, Danielpour D, Streilein J W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 1991; 32: 33–43
   Web of Science ®Google Scholar
• Jampel H D, Roche N, Stark W J, Roberts A B. Transforming growth factor-β in human aqueous humor. Curr. Eye Res. 1990; 9: 963–969
   PubMed Web of Science ®Google Scholar
• Granstein R, Staszewski R, Knisely T L, Zeira E, Nazareno R, Latina M, Albert D M. Aqueous humor contains transforming growth factor-β and a small (<3500 daltons) inhibitor of thymocyte proliferation. J. Immunol. 1990; 144: 3021–3026
   PubMed Web of Science ®Google Scholar
• Taylor A W, Streilein J W, Cousins S W. α-Melanocyte-stimulating hormone (α-MSH) suppresses immune-mediated inflammation. Neuroimmunomodulation 1994; 1: 188–194
   PubMedGoogle Scholar
• Taylor A W, Streilein J W, Cousins S W. Vasoactive intestinal peptide (VIP) contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 1994; 153: 1080–1086
   PubMed Web of Science ®Google Scholar
• Geppetti P, Del Bianco E, Cecconi R, Tramontana M, Romani A, Theodorsson E. Capsaicin releases calcitonin gene-related peptide from the human iris and ciliary body in vitro. Regul. Pept. 1992; 41: 83–92
   PubMedGoogle Scholar
• Knisely T L, Hosoi J, Nazareno R, Grandstein R D. The presence of biologically significant concentrations of glucocorticoids but little or no cortisol binding globulin with aqueous humor: relavance to immune privilege in the anterior chamber of the eye. Invest. Ophthalmol. Vis. Sci. 1994; 35: 3711–3723
   PubMed Web of Science ®Google Scholar
• Knisely T L, Bleicher P A, Vibbard C A, Granstein R D. Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells. Curr. Eye Res. 1991; 10: 761–771
   PubMed Web of Science ®Google Scholar
• Uddman R, Alumets J, Ehinger B, Hákanson R, Lorén I, Sundler F. Vasoactive intestinal peptide nerves in ocular and orbital structures of the cat. Invest. Ophthalmol. Vis. Sci. 1980; 19: 878–885
   PubMed Web of Science ®Google Scholar
• Drager U C, Edwards D L, Kleinschmidt J. Neurofilaments contain α-melanocyte-stimulating hormone (α-MSH)-like immunoreactivity. Proc. Natl. Acad. Sci. USA 1983; 80: 6408–6412
   PubMedGoogle Scholar
• Tinsely P W, Fridland G H, Killmar J T, Desiderio D M. Purification, characterization, and localization of neuropeptides in the cornea. Peptides 1988; 9: 1373–1379
   PubMedGoogle Scholar
• Niederkorn J Y, Benson J L, Mayhew E. Efferent blockade of delayed-type hypersensitivity. responses in the anterior chamber of the eye. Reg. Immunol. 1991; 3: 349–354
   Google Scholar
• Apte R S, Niederkorn J Y. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J. Immunol. 1996; 156: 2667–2673
   PubMed Web of Science ®Google Scholar
• Cousins S W, Trattler W B, Streilein J W. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr. Eye Res. 1991; 10: 287–297
   PubMed Web of Science ®Google Scholar
• Taylor A, Streilein J, Cousins S. Identification of alpha-melanocyte-stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 1992; 11: 1199–1206
   PubMed Web of Science ®Google Scholar
• Cherwinski H M, Schumacher J H, Brown K D, Mosmann T R. Two types of mouse helper cell clones: III. further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 1987; 166: 1229–1244
   PubMed Web of Science ®Google Scholar
• Cher D J, Mosmann T R. Two types of murine helper T-cell clone: II. delayed-type hypersensitivity is mediated by Th1 clones. J. Immunol. 1987; 138: 3688–3694
   PubMed Web of Science ®Google Scholar
• Fiorentino D F, Bond M W, Mosmann T R. Two types of mouse T-helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989; 170: 2081–2095
   PubMed Web of Science ®Google Scholar
• Chen Y, Kuchroo V K, Inobe J I, Hafler D A, Weiner H L. Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237–1240
   PubMed Web of Science ®Google Scholar
• Caspi R, Stiff L, Morawentz R, Miller-Rivero N, Chan C, Wiggert B, Nussenblatt R, Morse H, Rizzo L. Cytokine-dependent modulation of oral tolerance in a murine model of autoimmune uveitis. Ann. N.Y. Acad. Sci. 1996; 778: 315–324
   PubMed Web of Science ®Google Scholar
• Silver P, Rizzo L, Chan C, Donoso L, Wiggert B, Caspi R. Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest. Ophthalmol. Vis. Sci. 1995; 36: 946–954
   PubMed Web of Science ®Google Scholar
• Wang Z Y, Link H, Ljungdahl A, Hojeberg B, Link J, He B, Qiao J, Melms A, Olsson T. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immun. 1994; 157: 353–368
   PubMed Web of Science ®Google Scholar
• Lawrence D A. Identification and activation of latent transforming growth factor-β. Methods Enzymol. 1991; 198: 327–336
   PubMed Web of Science ®Google Scholar
• Alard P, Lantz O, Sebagh M, Calvo C F, Weill D, Chavanel G, Senik A, Charpentier B. A versatile ELISA-PCR assay for mRNA quantitation from a few cells. Biothechniques 1993; 15: 730–737
   PubMedGoogle Scholar
• Fargeas C, Wu C Y, Nakajima T, Cox D, Nutman T, Delespesse G. Differential effect of transforming growth factor beta on the synthesis of Th1-and Th2-like lymphokines by human T lymphocytes. Eur. J. Immunol. 1992; 22: 2173–2176
   PubMed Web of Science ®Google Scholar
• Fox F E, Ford H C, Douglas R, Cherian S, Nowell P C. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and auto-crine mechanisms. Cell. Immun. 1993; 150: 45–58
   PubMedGoogle Scholar
• Maeda H, Shiraishi A. TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 1996; 156: 73–78
   PubMed Web of Science ®Google Scholar
• Cerwenka A, Kovar H, Majdic O, Holter W. Fas- and activation-induced apoptosis are reduced in human T-cells preactivated in the presence of TGF-β1. J. Immunol. 1996; 156: 459–464
   PubMed Web of Science ®Google Scholar
• Hoehn P, Goedert S, Germann T, Koelsch S, Jin S, Palm N, Ruede E, Schmitt E. Opposing effects of TGF-β2 on the Th1 cell development of naive CD4+ T-cells isolated from different mouse strains. J. Immunol. 1995; 155: 3788–3793
   PubMed Web of Science ®Google Scholar
• Murry J S, Madri J, Pasqualini T, Bottomly K. Functional CD4 T-cell subset interplay in an intact immune system. J. Immunol. 1993; 150: 4270–4276
   PubMed Web of Science ®Google Scholar
• Karpus W J, Swanborg R H. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-β. J. Immunol. 1991; 146: 1163–1168
   PubMed Web of Science ®Google Scholar
• Miller A, Lider O, Roberts A B, Sporn M B, Weine H L. Suppressor T-cells generated by oral tolerization to myelin basic protein suppress both in vitro in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 1992; 89: 421–425
   PubMed Web of Science ®Google Scholar
• Chen Y H, Weiner H L. Dose-dependent activation and deletion of antigen-specific T-cells following oral tolerance. Ann. N.Y. Acad. Sci. 1996; 778: 111–121
   PubMedGoogle Scholar
• Caspi R R, Roberge F G, Cahn C C, Wigget B, Chader G J, Rozenszajn L A, Lando Z, Nussenblatt R B. A new model of autoimmune disease; experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 1988; 140: 1490–1495
   PubMed Web of Science ®Google Scholar
• Caspi R R, Silver P B, Chan C C, Sun B, Agarwal R K, Wells J, Oddo S, Fujino Y, Najafian F, Wilder R L. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with elevated Th1 response. J. Immunol. 1996; 157: 2668–2675
   PubMedGoogle Scholar
• Gery I, Streilein J W. Autoimmunity in the eye and its regulation. Curr. Opinion Immunol. 1994; 6: 938–945
   PubMed Web of Science ®Google Scholar
• Savion S, Oddo S, Grover S, Caspi R R. Uveitogenic Tlymphocytes in the rat: pathogenicity vs. lymphokine production, adhesion molecules and surface antigen expression. J. Neuroimmun. 1994; 55: 35–44
   PubMed Web of Science ®Google Scholar
• Butler T L, McMenamin P G. Resident and infliltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 1996; 37: 2195–2210
   PubMed Web of Science ®Google Scholar
• Streilein J W. Peripheral tolerance induction: lessons from immune-privileged sites and tissues. Transp. Proc. 1996; 28: 2066–2070
   PubMed Web of Science ®Google Scholar